Curi Bio lands $6m Series A

Curi Bio Inc, a developer of human stem cell-based platforms for drug discovery, has raised $6 million in Series A financing.

Curi Bio Inc, a developer of human stem cell-based platforms for drug discovery, has raised $6 million in Series A financing. Dynamk Capital led the round.

Source: Press Release